1 To compare the mean duration (days) for reduction in disease severity ordinal scale by 1 in patients supplemented with ImmuActive and placebo. <br/ >2 To compare the mean number of patients with reduction in disease severity by 1 ordinal scale in ImmuActive and placebo.Timepoint: 1 To compare the mean duration (days) for reduction in disease severity ordinal scale by 1 in patients supplemented with ImmuActive and placebo (Day1 to anytime during the study till 28Days). <br/ >2 To compare the mean number of patients with reduction in disease severity by 1 ordinal scale in ImmuActive and placebo (Day1 to anytime during the study till 28Days).

1 To compare the mean duration (days) for reduction in disease severity ordinal scale by 1 in patients supplemented with ImmuActive and placebo. <br/ >2 To compare the mean number of patients with reduction in disease severity by 1 ordinal scale in ImmuActive and placebo.Timepoint: 1 To compare the mean duration (days) for reduction in disease severity ordinal scale by 1 in patients supplemented with ImmuActive and placebo (Day1 to anytime during the study till 28Days). <br/ >2 To compare the mean number of patients with reduction in disease severity by 1 ordinal scale in ImmuActive and placebo (Day1 to anytime during the study till 28Days).

N/A

N/A

1 To compare the mean duration (days) for reduction in disease severity ordinal scale by 1 in patients supplemented with ImmuActive and placebo. <br/ >2 To compare the mean number of patients with reduction in disease severity by 1 ordinal scale in ImmuActive and placebo.Timepoint: 1 To compare the mean duration (days) for reduction in disease severity ordinal scale by 1 in patients supplemented with ImmuActive and placebo (Day1 to anytime during the study till 28Days). <br/ >2 To compare the mean number of patients with reduction in disease severity by 1 ordinal scale in ImmuActive and placebo (Day1 to anytime during the study till 28Days).

1 To compare the mean duration (days) for reduction in disease severity ordinal scale by 1 in patients supplemented with ImmuActive and placebo. <br/ >2 To compare the mean number of patients with reduction in disease severity by 1 ordinal scale in ImmuActive and placebo.Timepoint: 1 To compare the mean duration (days) for reduction in disease severity ordinal scale by 1 in patients supplemented with ImmuActive and placebo (Day1 to anytime during the study till 28Days). <br/ >2 To compare the mean number of patients with reduction in disease severity by 1 ordinal scale in ImmuActive and placebo (Day1 to anytime during the study till 28Days).